Navigation Links
Echo Therapeutics Announces Symphony™ tCGM System Progress
Date:5/23/2011

PHILADELPHIA, May 23, 2011 /PRNewswire/ -- Echo Therapeutics, Inc. (OTCBB: ECTE), a company developing the Symphony™ tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and the Prelude™ SkinPrep System for transdermal drug delivery, announced that it has received the key components of its next generation Symphony tCGM System design.  This newly-engineered design is currently undergoing its final functionality testing.

The updated Symphony System will be ready for demonstration in the very near-term.  Importantly, it will be further tested in a final series of clinical trials shortly thereafter, replacing the prototype used in earlier clinical trials.  

This next generation design incorporates numerous technological advances required to meet market expectations for system accuracy, manufacturability and product cost.  Echo believes that upon completion of the final development work, no significant changes will be made to the Symphony tCGM System, and that the newly-engineered device will be used for sale, subject to positive clinical studies and FDA market clearance of the product.  The addressable market for needle-free, continuous wireless glucose monitoring in the hospital critical care setting exceeds $1 billion annually and the global glucose monitoring market exceeds $12 billion annually.

"We are excited to commence what we hope are the final series of modifications and testing as we move closer to our goal of a pivotal study which would form the basis of our application to the FDA for marketing clearance of the product-candidate," said Patrick T. Mooney, M.D., Chairman and CEO of Echo Therapeutics.  "We look forward to an exciting year of development progress and validating the improvements that we have made in clinical testing."  

The Symphony tCGM System consists of Echo's proprietary Prelude SkinPrep System, with a noninvasive w
'/>"/>

SOURCE Echo Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Sangamo BioSciences and Collaborators Present Data Showcasing Broad Applications of ZFP Therapeutics®
2. Serina Therapeutics Awarded Patent for Its Core Polymer Drug Delivery Technology
3. Pearl Therapeutics Phase 2b Results Show a 50% Improvement in Lung Function with PT003 Compared to Spiriva® and Foradil® in Patients with COPD
4. Translational Science Expert, Dr. Melissa Ashlock, Joins aTyr Pharma to Advance Physiocrine-based Therapeutics
5. Regency Therapeutics and Daiichi Sankyo Announce Launch and Commercial Availability of SPRIX® (ketorolac tromethamine) Nasal Spray
6. Inhibikase Therapeutics Elects Steven C. Gilman, Ph.D., to Board of Directors
7. Echo Therapeutics Appoints Christopher P. Schnittker as Chief Financial Officer
8. Healthpoint Biotherapeutics Introduces OASIS® Ultra Tri-Layer Matrix
9. Halozyme Therapeutics and ViroPharma Announce $83 Million Global Licensing Agreement to Develop Subcutaneous Cinryze® (C1 esterase inhibitor [human])
10. Orexigen® Therapeutics Reports First Quarter Ended March 31, 2011 Financial Results
11. Cell Therapeutics Announces Planned Reverse Stock Split; Receives NASDAQ Notice of Non-Compliance; Intends to Request Hearing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)...   Ventana Medical Systems, Inc.  (Ventana), a ... its VENTANA System for Primary Diagnosis 1 ... for routine pathology, including primary diagnosis with human ... software coupled with either the VENTANA iScan Coreo ... automated digital slide creation, case management and computer ...
(Date:8/20/2014)... LAKE CITY , Aug. 20, 2014 ... revolutionary mobile diagnostic platform during a special event at ... Utah , on September 5, 2014. The event, ... LiveStreamed on the ApolloDx website, www.apollodx.com .    ... transform diagnostic testing," said Jared Bauer , Co-Founder ...
(Date:8/20/2014)... , Aug. 20, 2014 Trovagene, Inc. ... announced today that results from two clinical studies will ... for the Company,s urine-based diagnostic test for the detection ... IPV conference is scheduled to take place in ... to 25 th . Additionally, a new U.S. patent ...
Breaking Medicine Technology:Full digitization of the anatomic pathology lab is here with the VENTANA System for Primary Diagnosis 2Full digitization of the anatomic pathology lab is here with the VENTANA System for Primary Diagnosis 3Trovagene Provides Update on Its Urine-Based HPV Test 2Trovagene Provides Update on Its Urine-Based HPV Test 3
... HeartWare International, Inc. (NASDAQ: HTWR ... miniaturized circulatory support technologies that are revolutionizing the treatment ... Godshall is scheduled to present at the Lazard Capital ... p.m. ET on Thursday, September 22, 2011.  The one-day ...
... and SEATTLE, Sept. 19, 2011 Varian ... Calypso Medical Technologies, Inc., today announced they have signed ... a privately-owned, Seattle-based developer and supplier of specialized products ... during radiosurgery and radiotherapy.  The acquisition, which is anticipated ...
Cached Medicine Technology:HeartWare to Present at The Lazard Capital Markets 3rd Annual Circulatory Assist Device Day 2Varian Medical Systems Signs Agreement to Acquire Calypso Medical Technologies; Acquisition Adds Products for Tracking Tumor Motion During Radiosurgery and Radiotherapy 2Varian Medical Systems Signs Agreement to Acquire Calypso Medical Technologies; Acquisition Adds Products for Tracking Tumor Motion During Radiosurgery and Radiotherapy 3Varian Medical Systems Signs Agreement to Acquire Calypso Medical Technologies; Acquisition Adds Products for Tracking Tumor Motion During Radiosurgery and Radiotherapy 4Varian Medical Systems Signs Agreement to Acquire Calypso Medical Technologies; Acquisition Adds Products for Tracking Tumor Motion During Radiosurgery and Radiotherapy 5
(Date:8/20/2014)... Missouri federal judge has remanded a lawsuit filed by a ... NaturaLyte to the City of St. Louis Circuit Court, reports ... rejected an assertion by the defendants that the plaintiffs’ claims ... v. Fresenius Medical Care North America Inc., et al., No. ... of the dialysis products GranuFlo and NaturaLyte. In 2012, the ...
(Date:8/20/2014)... News) -- Leaving the car at home and getting to ... your health, a new study indicates. Researchers looked at ... 76 percent of men and 72 percent of women drove ... women used public transit, and 14 percent of men and ... drove to work weighed more and had higher levels of ...
(Date:8/20/2014)... The Workgroup for Electronic Data Interchange ... use of health IT to create efficiencies in ... its annual fall conference, WEDI-Con 2014: The Next ... take place at the HYATT Regency in Reston, ... cross-section of payers, providers, government regulators, industry vendors ...
(Date:8/20/2014)... WI (PRWEB) August 20, 2014 Parents ... While the transition from summer months means buying textbooks ... element that is often a forgotten part of the ... , According to the American Psychological Association, 27% of ... year. Nearly half (45%) say they are stressed by ...
(Date:8/20/2014)... (PRWEB) August 20, 2014 Verndale is ... Inc. 500|5000 list; an exclusive list ranking the fastest-growing ... are ranked according to their yearly percentage revenue growth ... 8th time on the Inc. 5000 list where it ... Company, Verndale offers its clients a wide range of ...
Breaking Medicine News(10 mins):Health News:GranuFlo/NaturaLyte Case Remanded to State Court By Missouri Federal Judge, Baron and Budd Reports 2Health News:Want to Stay Slim? Leave the Car at Home 2Health News:WEDI Releases Full Conference Agenda for Its Annual Fall Conference – WEDI-Con 2014 2Health News:WEDI Releases Full Conference Agenda for Its Annual Fall Conference – WEDI-Con 2014 3Health News:Five Easy Steps to Help Your Child Manage Back-to-school Stress 2Health News:Five Easy Steps to Help Your Child Manage Back-to-school Stress 3Health News:For the 8th Time, Verndale Has Been Honored on the Inc. 5000 List 2
... Simple exercise routines can improve lung function and overall fitness ... a small new study suggest. Cystic fibrosis, or CF, ... mucus in the lungs, resulting in frequent lung infections, breathing ... regimens are difficult to adhere to long-term, so a team ...
... at The Scripps Research Institute have found a temperature-sensing protein within ... activate an immune response. This process can occur as temperature rises, ... immune cells are "called" from the body,s warm interior to a ... online ahead of print by Nature Chemical Biology , is ...
... FRIDAY, May 6 (HealthDay News) -- Nail salon workers may ... a new study warns. Researchers recruited 80 Vietnamese women ... their work-related exposure to toluene, ethyl acetate and isopropyl acetate. ... Journal of Public Health , showed that the workers were ...
... bacteria associated with exposure to livestock was recently discovered ... contact with livestock, according to University of Iowa researchers. ... study of Staphylococcus aureus in child day care facilities ... in the UI College of Public Health, for her ...
... Reinberg HealthDay Reporter , THURSDAY, May ... antibiotics can often cure appendicitis, surgery remains the ... appendicitis may be treated with antibiotics alone, but ... surgery, and it is difficult to discern between ...
... May 6 (HealthDay News) -- Americans walked and biked a ... new research finds. But the increases were minor, especially ... in the American Journal of Public Health . ... 2009 U.S. National Household Travel Surveys and found that the ...
Cached Medicine News:Health News:Everyday Exercise Can Help Kids With Cystic Fibrosis: Study 2Health News:Scripps Research scientists show how shifts in temperature prime immune response 2Health News:Scripps Research scientists show how shifts in temperature prime immune response 3Health News:Study finds livestock-related 'Staph' strain in child care worker 2Health News:Surgery May Beat Antibiotics for Appendicitis, Study Finds 2Health News:Surgery May Beat Antibiotics for Appendicitis, Study Finds 3Health News:Americans Walking, Biking a Bit More, Research Shows 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: